Stefano Guerra1. 1. Centre for Research in Environmental Epidemiology, IMIM-Hospital del Mar, CIBERESP, Barcelona, Spain. sguerra@creal.cat
Abstract
PURPOSE OF REVIEW: In the clinical setting, patients who present with a combination of asthma and chronic obstructive pulmonary disease (COPD)-related traits are not uncommon. This review discusses recent advances in the characterization of the natural course, phenotypes, and molecular markers of cases with coexisting asthma and COPD and in the understanding of the nature of the link between these two conditions. RECENT FINDINGS: Recent epidemiological evidence indicates that asthma accounts for a substantial proportion of cases of irreversible airflow limitation in the general population and that, in addition to the critical role of environmental exposures in adult age, alterations of developmental processes in childhood may also predispose patients with asthma to COPD later in life. Findings from clinical and experimental studies emphasize the existence of remarkable heterogeneity within the group of patients with coexisting asthma and COPD in terms of natural history of lung function, risk factors for disease progression, lung structural changes, and immunological profiles. SUMMARY: The phenotypic complexity of cases with coexisting asthma and COPD challenges a rigid categorization of patients into existing diagnostic labels and suggests the importance of integrating clinical, functional, morphologic, immunological, and molecular assessments to tailor and optimize prevention and treatment.
PURPOSE OF REVIEW: In the clinical setting, patients who present with a combination of asthma and chronic obstructive pulmonary disease (COPD)-related traits are not uncommon. This review discusses recent advances in the characterization of the natural course, phenotypes, and molecular markers of cases with coexisting asthma and COPD and in the understanding of the nature of the link between these two conditions. RECENT FINDINGS: Recent epidemiological evidence indicates that asthma accounts for a substantial proportion of cases of irreversible airflow limitation in the general population and that, in addition to the critical role of environmental exposures in adult age, alterations of developmental processes in childhood may also predispose patients with asthma to COPD later in life. Findings from clinical and experimental studies emphasize the existence of remarkable heterogeneity within the group of patients with coexisting asthma and COPD in terms of natural history of lung function, risk factors for disease progression, lung structural changes, and immunological profiles. SUMMARY: The phenotypic complexity of cases with coexisting asthma and COPD challenges a rigid categorization of patients into existing diagnostic labels and suggests the importance of integrating clinical, functional, morphologic, immunological, and molecular assessments to tailor and optimize prevention and treatment.
Authors: A Papi; M Romagnoli; S Baraldo; F Braccioni; I Guzzinati; M Saetta; A Ciaccia; L M Fabbri Journal: Am J Respir Crit Care Med Date: 2000-11 Impact factor: 21.405
Authors: T B Grydeland; A Dirksen; H O Coxson; S G Pillai; S Sharma; G E Eide; A Gulsvik; P S Bakke Journal: Eur Respir J Date: 2009-03-26 Impact factor: 16.671
Authors: M Weatherall; J Travers; P M Shirtcliffe; S E Marsh; M V Williams; M R Nowitz; S Aldington; R Beasley Journal: Eur Respir J Date: 2009-04-08 Impact factor: 16.671
Authors: Paul Van Eerdewegh; Randall D Little; Josée Dupuis; Richard G Del Mastro; Kathy Falls; Jason Simon; Dana Torrey; Sunil Pandit; Joyce McKenny; Karen Braunschweiger; Alison Walsh; Ziying Liu; Brooke Hayward; Colleen Folz; Susan P Manning; Alicia Bawa; Lisa Saracino; Michelle Thackston; Youssef Benchekroun; Neva Capparell; Mei Wang; Ron Adair; Yun Feng; JoAnn Dubois; Michael G FitzGerald; Hui Huang; René Gibson; Kristina M Allen; Alex Pedan; Melvyn R Danzig; Shelby P Umland; Robert W Egan; Francis M Cuss; Steuart Rorke; Joanne B Clough; John W Holloway; Stephen T Holgate; Tim P Keith Journal: Nature Date: 2002-07-10 Impact factor: 49.962
Authors: W M Vollmer; Thorn Gíslason; P Burney; P L Enright; A Gulsvik; A Kocabas; A S Buist Journal: Eur Respir J Date: 2009-05-21 Impact factor: 16.671
Authors: M Bafadhel; S Saha; R Siva; M McCormick; W Monteiro; P Rugman; P Dodson; I D Pavord; P Newbold; C E Brightling Journal: Respiration Date: 2009-05-27 Impact factor: 3.580
Authors: Medea Imboden; Emmanuelle Bouzigon; Ivan Curjuric; Adaikalavan Ramasamy; Ashish Kumar; Dana B Hancock; Jemma B Wilk; Judith M Vonk; Gian A Thun; Valerie Siroux; Rachel Nadif; Florent Monier; Juan R Gonzalez; Matthias Wjst; Joachim Heinrich; Laura R Loehr; Nora Franceschini; Kari E North; Janine Altmüller; Gerard H Koppelman; Stefano Guerra; Florian Kronenberg; Mark Lathrop; Miriam F Moffatt; George T O'Connor; David P Strachan; Dirkje S Postma; Stephanie J London; Christian Schindler; Manolis Kogevinas; Francine Kauffmann; Debbie L Jarvis; Florence Demenais; Nicole M Probst-Hensch Journal: J Allergy Clin Immunol Date: 2012-03-16 Impact factor: 10.793